中医疗法治疗68例支气管肺癌临床分析

Clinical analysis of treating 68 cases of lung cancer in TCM

目的:探讨中医疗法治疗支气管肺癌的临床疗效。方法:对我院2008年1月～2011年1月采用中医疗法治疗的68例支气管肺癌患者的临床资料进行回顾性分析。结果:68例患者中,部分缓解39例,占57.35%;稳定21例,占30.88%;进展8例,占11.77%,客观有效率(RR)为57.35%,疾病控制率(DC)为88.24%。治疗前、后Karnofsky评分分别为(47.36±9.72),(65.31±11.27);治疗后明显高于治疗前(P<0.05)。6例患者出现不良反应:恶心、呕吐(4例),头晕(1例)、肝肾功能损害(1例)。讨论:中医治疗支气管肺癌具有良好的疗效,可延长患者生存期,提高患者的生活质量,且不良反应小,若结合化疗,有望进一步提高支气管肺癌的治愈率,值得临床推广使用。

Objective： To investigate the clinical efficacy of TCM on treating lung cancer.Methods： The clinical data of 68 cases of lung cancer patients that were treated in TCM in the hospital from January 2008 to 2011 January was analyzed retrospectively.Results： Partial remission in 39 cases,accounting for 57.35%;stability of 21 cases,accounting for 30.88%;progress in 8 cases,accounting for 11.77%,the objective response rate（RR） was 57.35%,disease control rate（DC） was 88.24 %.Before and after treatment,the Karnofsky score were（47.36±9.72） and（65.31±11.27）;the effect of after treatment was significantly higher（P0.05）.6 patients with adverse reactions： nausea,vomiting（4 cases）,dizziness（1 case）,liver and kidney dysfunction（1 case）.Discussion： The effect of TCM on treating bronchial lung cancer was good,it can prolong the survival period and improve the quality of life of patients with adverse reactions,if combined with chemotherapy,it is expected to further improve the cure rate of bronchogenic carcinoma,worthy of promoting.